Cytonics
Our mission is to rid the world of the pain, suffering, and reduced quality of life caused by Osteoarthritis (OA).
Overview
Raised: $2,896,943
Rolling Commitments ($USD)
Active
04/27/2024
31
28,975%
60%
$21,146
1,321
2006
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Low
High
Summary Profit and Loss Statement
FY 2023 | FY 2022 | |
---|---|---|
Revenue |
$417,500 |
$405,000 |
COGS |
$2,370,360 |
$3,175,764 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-2,844,674 |
$-1,927,629 |
Summary Balance Sheet
FY 2023 | FY 2022 | |
---|---|---|
Cash |
$602,933 |
$1,166,390 |
Accounts Receivable |
$120,000 |
$100,000 |
Total Assets |
$1,030,187 |
$1,437,976 |
Short-Term Debt |
$295,503 |
$304,246 |
Long-Term Debt |
$176,319 |
$0 |
Total Liabilities |
$471,822 |
$304,246 |
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Cytonics | 05/27/2024 | StartEngine | $65,792,080 | $2,896,943 | Equity - Preferred | Active | RegCF |
Cytonics | 03/30/2023 | Dealmaker Securities | $58,915,995 | $1,695,868 | Equity - Preferred | Funded | RegCF |
Cytonics | 10/13/2022 | SeedInvest | $58,915,996 | $2,633,766 | Equity - Preferred | Funded | RegCF / RegD 506(c) |
Cytonics | 04/29/2021 | SeedInvest | $46,701,000 | $4,667,638 | Equity - Preferred | Funded | RegA+ |
Cytonics | 05/17/2019 | SeedInvest | $32,400,000 | $494,344 | Convertible Note | Funded | RegCF / RegD 506(c) |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual